Financing ·
Tvardi Therapeutics, Inc. amended its Capital on Demand☖ Sales Agreement with JonesTrading Institutional Services LLC…
TVRDTvardi Therapeutics, Inc.
Tvardi Therapeutics, Inc. amended its Capital on Demand☖ Sales Agreement with JonesTrading Institutional Services LLC to increase its at-the-market offering program by up to $9,689,765 in additional common stock. The company's previous 12-month sales under the following agreement were approximately $11.0 million in gross proceeds. Tvardi Therapeutics, Inc. is a biotechnology company focused on developing therapeutic solutions for cancer.